GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Concert Pharmaceuticals Inc (FRA:73C) » Definitions » Total Premiums Earned

Concert Pharmaceuticals (FRA:73C) Total Premiums Earned


View and export this data going back to 2014. Start your Free Trial

What is Concert Pharmaceuticals Total Premiums Earned?

Total Premiums Earned only applies to insurance companies.


Concert Pharmaceuticals (FRA:73C) Business Description

Traded in Other Exchanges
N/A
Address
65 Hayden Avenue, Suite 3000N, Lexington, MA, USA, 02421
Concert Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company aims to discover and develop small-molecule drugs by incorporating new elements into known molecules or by leveraging the currently approved drugs to be used for new treatments. The pipeline consists of small molecules designed for oral administration to cure cystic fibrosis, inflammation, narcolepsy, residual schizophrenia, major depressive disorder, and Alzheimer's agitation.